Paige.AI nabs $25M, inks IP deal with Sloan Kettering to bring machine learning to cancer pathology

Artificial intelligence has become one of the key weapons in the fight against cancer and the many forms and mutations that it takes, and today a startup is coming out of stealth and and announcing funding and a significant data deal as it seeks to build an AI system specifically to help understand one aspect of the treatment cycle: cancer pathology. New York-based Paige.AI — an… Read More